SIA
Soltis Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $335K | Sell |
638
-18
| -3% | -$9.44K | 0.03% | 303 |
|
|
2025
Q1 | $416K | Sell |
656
-21
| -3% | -$13.3K | 0.04% | 259 |
|
|
2024
Q4 | $482K | Sell |
677
-34
| -5% | -$24.2K | 0.04% | 244 |
|
|
2024
Q3 | $747K | Buy |
711
+28
| +4% | +$29.4K | 0.07% | 176 |
|
|
2024
Q2 | $717K | Buy |
683
+9
| +1% | +$9.45K | 0.08% | 173 |
|
|
2024
Q1 | $649K | Sell |
674
-9
| -1% | -$8.67K | 0.07% | 176 |
|
|
2023
Q4 | $600K | Sell |
683
-42
| -6% | -$36.9K | 0.07% | 171 |
|
|
2023
Q3 | $597K | Sell |
725
-9
| -1% | -$7.41K | 0.08% | 162 |
|
|
2023
Q2 | $528K | Sell |
734
-8
| -1% | -$5.75K | 0.06% | 167 |
|
|
2023
Q1 | $610K | Buy |
742
+47
| +7% | +$38.6K | 0.08% | 155 |
|
|
2022
Q4 | $502K | Sell |
695
-10
| -1% | -$7.22K | 0.07% | 170 |
|
|
2022
Q3 | $486K | Buy |
705
+63
| +10% | +$43.4K | 0.07% | 164 |
|
|
2022
Q2 | $380K | Buy |
642
+11
| +2% | +$6.51K | 0.06% | 176 |
|
|
2022
Q1 | $441K | Buy |
631
+45
| +8% | +$31.5K | 0.06% | 172 |
|
|
2021
Q4 | $370K | Sell |
586
-2
| -0.3% | -$1.26K | 0.05% | 185 |
|
|
2021
Q3 | $356K | Buy |
588
+4
| +0.7% | +$2.42K | 0.06% | 178 |
|
|
2021
Q2 | $326K | Buy |
584
+29
| +5% | +$16.2K | 0.05% | 191 |
|
|
2021
Q1 | $263K | Buy |
555
+11
| +2% | +$5.21K | 0.05% | 188 |
|
|
2020
Q4 | $263K | Buy |
544
+13
| +2% | +$6.29K | 0.05% | 189 |
|
|
2020
Q3 | $297K | Buy |
531
+31
| +6% | +$17.3K | 0.07% | 166 |
|
|
2020
Q2 | $312K | Hold |
500
| – | – | 0.08% | 151 |
|
|
2020
Q1 | $244K | Buy |
+500
| New | +$244K | 0.08% | 141 |
|